Search Within

Elisa De Stanchina

  1. "Division of Subspecialty Medicine "
Formats
  1. Journal Article (11)
Groups
  1. Department of Medicine (11)
  2. Division of Subspecialty Medicine (11)
  3. GSK Faculty (9)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)
  5. Human Oncology and Pathogenesis Program (8)
  6. Sloan Kettering Institute Postdocs (8)

More Groups

People
  1. James Fagin (5)
  2. Gnana Prakasam Krishnamoorthy (4)
  3. Mahesh Saqcena (4)
  4. Bin Xu (3)
  5. Jeffrey Knauf (3)
  6. Ronald Ghossein (3)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (2)
  5. 2019 (1)
  6. 2012 (1)

More Years

Publications
  1. Cancer Cell (2)
  2. Cancer Discovery (2)
  3. Cancer Immunology, Immunotherapy (1)
  4. Endocrine-Related Cancer (1)
  5. Experimental Biology and Medicine (1)
  6. Frontiers in Pharmacology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. Cell Press (2)
  3. Biomed Central Ltd (1)
  4. Bioscientifica Ltd (1)
  5. Frontiers Media S.A. (1)
  6. Nature Publishing Group (1)

More Publishers

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs
    Journal Article

    Krishnamoorthy, G. P.; Glover, A. R.; Untch, B. R.; Sigcha-Coello, N.; Xu, B.; Vukel, D.; Liu, Y.; Tiedje, V.; Pineda, J. M. B.; Berman, K.; more...
    Journal of Experimental Medicine (2025)

    Fulltext@MSK | Save
  • Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
    Journal Article

    Pai, J. A.; Hellmann, M. D.; Sauter, J. L.; Mattar, M.; Rizvi, H.; Woo, H. J.; Shah, N.; Nguyen, E. M.; Uddin, F. Z.; Quintanal-Villalonga, A.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
    Journal Article

    Chatila, W. K.; Walch, H.; Hechtman, J. F.; Moyer, S. M.; Sgambati, V.; Faleck, D. M.; Srivastava, A.; Tang, L.; Benhamida, J.; Ismailgeci, D.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors
    Journal Article

    Garcia-Rendueles, M. E. R.; Krishnamoorthy, G.; Saqcena, M.; AcunĖƒa-Ruiz, A.; Revilla, G.; de Stanchina, E.; Knauf, J. A.; Lester, R.; Xu, B.; Ghossein, R. A.; more...
    Molecular Cancer (2022)

    Fulltext@MSK | Save
  • Kidney-targeted redox scavenger therapy prevents cisplatin-induced acute kidney injury
    Journal Article

    Williams, R. M.; Shah, J.; Mercer, E.; Tian, H. S.; Thompson, V.; Cheung, J. M.; Dorso, M.; Kubala, J. M.; Gudas, L. J.; de Stanchina, E.; more...
    Frontiers in Pharmacology (2022)

    Fulltext@MSK | Save
  • Co-inhibition of SMAD and MAPK signaling enhances (124)I uptake in BRAF-mutant thyroid cancers
    Journal Article

    Luckett, K. A.; Cracchiolo, J. R.; Krishnamoorthy, G. P.; Leandro-Garcia, L. J.; Nagarajah, J.; Saqcena, M.; Lester, R.; Im, S. Y.; Zhao, Z.; Lowe, S. W.; more...
    Endocrine-Related Cancer (2021)

    Fulltext@MSK | Save
  • SWI/SNF complex mutations promote thyroid tumor progression and insensitivity to redifferentiation therapies
    Journal Article

    Saqcena, M.; Leandro-Garcia, L. J.; Maag, J. L. V.; Tchekmedyian, V.; Krishnamoorthy, G. P.; Tamarapu, P. P.; Tiedje, V.; Reuter, V.; Knauf, J. A.; de Stanchina, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer
    Journal Article

    Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas
    Journal Article

    Lito, P.; Pratilas, C. A.; Joseph, E. W.; Tadi, M.; Halilovic, E.; Zubrowski, M.; Huang, A.; Wong, W. L.; Callahan, M. K.; Merghoub, T.; more...
    Cancer Cell (2012)

    Fulltext@MSK | Save
  • Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity
    Journal Article

    Lin, H.; de Stanchina, E.; Zhou, X. K.; Hong, F.; Seidman, A.; Fornier, M.; Xiao, W. L.; Kennelly, E. J.; Wesa, K.; Cassileth, B. R.; more...
    Cancer Immunology, Immunotherapy (2010)

    Fulltext@MSK | Save